Last month, the PhRMA Foundation announced the recipients of the inaugural Challenge Awards at Morning Consult. These awards recognize the best and the brightest that are identifying transformative solutions to measure value in health care and advance a value-driven health care system. The Challenge Awards are the first phase in the multi-year Value Assessment Initiative that will award over $1 million to advance the field of value assessment.
Recipients of the PhRMA Foundation 2017 Challenge Awards are:
TIED FOR FIRST PLACE:
- A Framework for Measuring Low-Value Care, Altarum
- It has been estimated that more than 30 percent of health care spending in the U.S. is wasteful. Low-value care, which drives up costs unnecessarily while increasing patient risk, is a significant component of this wasteful spending. Altarum’s winning paper summarizes and critiques existing methods that measure low-value care and describes an integrated framework that combines multiple methods to comprehensively estimate and track the magnitude and principal sources of clinical waste.
- Improving Value for Eczema Patients, National Eczema Association
- With the cost of chronic diseases now representing a majority of spending in the United States health care system, a reliable model to measure value is critical to identify replicable improvement methods. The National Eczema Association’s (NEA) plan to establish a Shared Decision Making Resource Center is a transformative strategy that can evaluate value of health care interventions for eczema patients to advance a value-driven health care system in the U.S.
SECOND PLACE:
- Emerging Good Practices for Transforming Value Assessment: Patients’ Voices, Patients’ Values, National Health Council and The University of Maryland School of Pharmacy
- Most U.S. value frameworks and subsequent assessments are developed with little to no patient engagement. The National Health Council (NHC) started a value workgroup in 2016 to change this. In the past two years, patient advocacy group engagement with value framework developers and assessors has increased, with groups reporting both positive experiences and challenges in their interactions. The NHC will use these early experiences can help recommend emerging good practices that can eventually get the field to implement standards for patient engagement.
THIRD PLACE:
- Patient Report Outcome Measures to Advance a Value-Driven Health Care System, University of Michigan
- Patient reported outcome measures (PROMs) are tools that assess patient perspectives on their health without interpretation by any other parties, and they are key tools in clinical research. The integration of electronically-delivered PROMs in clinical practices can dramatically change health outcomes by influencing decision-making. The authors of this paper propose that the implementation of generic and disease/condition specific PROMs across health care systems will advance a value-driven health care system.
Presentations from the Challenge Awards winners are available here. For more information on the PhRMA Foundation’s Value Assessment Initiative, please visit http://www.phrmafoundation.org/2018-awards/value-assessment-initiative
Eileen Cannon
Eileen is the former president of the PhRMA Foundation. After 22 years leading the Foundation, she retired in October 2021.
Eileen Cannon
PhRMA Foundation celebrates 60 years of investing in future scientific leaders
Incomplete evaluations undermine patient access to transformational medicine
3 things about the PhRMA Foundation
Innovative contracts continue to gain traction and improve quality of care
Growth in innovative, value-based contracts holds promise for the health system and for patients
Guest post: Value-based agreements can improve outcomes and even save patients money at the pharmacy counter
New data show how ICER’s value framework could prevent or delay access to treatments for Medicaid patients across the country
5 Ways to improve ICER’s value assessment framework
Assessing value top of mind at ISPOR 2019
Event tomorrow: Leaders convene to discuss solutions to advance value-driven health care
Safe and effective prescribing: A new and important initiative from the PhRMA Foundation
New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers
Guest post: Developing new payment models to ensure patients have access to high-investment therapies
Number of value-based contracts continues to rise
ICER’s budget impact threshold: Sounding a false alarm on affordability and access
PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs
How ICER’s assessment of a new class of migraine treatments fails patients
Aspen Spotlight Health: Discussing the forefront of innovation
New analysis shows that HTA organizations may frequently restrict access to cancer treatments
New analysis shows negative impact of ICER’s value framework on patient access in Medicare Part B
ICYMI: Recent survey adds to growing body of research on barriers to innovative payment approaches
Event tomorrow: Improving patient access to lifesaving medicines
Reality check: Value-based contracts are good for patients
Video: Barriers to results-based contracts
Improving care quality by engaging patients in shared decision making
ICYMI: Research shows promise of innovative payment arrangements in reducing costs, improving access
Clarity around anti-kickback statute needed to promote innovative payment arrangements
Video: What is a results-based contract?
The journey to better health care requires a holistic view
Medicare Monday: How Part B has evolved over the years
Modernizing FDA regulations to advance a value-driven health care system
ICYMI: Avalere and FasterCures develop new value framework from patient perspective
RA medicines often demonstrate far greater benefits to patients than initially understood
New analysis: More than half of patients’ out-of-pocket spending for brand medicines is based on full list price
Stakeholders Agree: Modernize the legal framework to support move to value-driven health care
How do multiple sclerosis patients define value?
PhRMA CEO talks White House meeting, innovation & jobs with POLITICO’s Pulse Check
VIDEO: PhRMA CEO discusses #GOBOLDLY campaign and White House meeting with CNNMoney’s Maggie Lake
The Value Collaborative: Advancing private market solutions to achieve better health, lower costs
PhRMA Foundation recognizes inaugural Challenge Award recipients
PhRMA Foundation
Value-Driven Health Care
PhRMA Foundation recognizes inaugural Challenge Award recipients
PhRMA Foundation recognizes inaugural Challenge Award recipients